Companies similar to IMMUNITYBIO INC (IBRX)
Health Care · NASDAQ
IMMUNITYBIO INC (IBRX)'s closest peers include CELLDEX THERAPEUTICS INC (CLDX), NEKTAR THERAPEUTICS (NKTR) and Moderna (MRNA). This peer set is drawn from IBRX's enriched company profile and is informational only — not financial advice.
Similar companies
-
CELLDEX THERAPEUTICS INCCLDXHealth Care
A clinical-stage biopharmaceutical company developing mast cell-targeted monoclonal and bispecific antibodies for chronic urticaria, inflammatory skin…
$35.40 (as of 2026-07-16) · market cap $2.7B
-
NEKTAR THERAPEUTICSNKTRHealth Care
Clinical-stage immunotherapy company developing regulatory T cell-targeted treatments for autoimmune diseases and cancer.
$67.05 (as of 2026-07-16) · market cap $2.3B
-
ModernaMRNAHealth Care
Moderna is an unprofitable mRNA vaccine and therapeutic company pivoting from peak COVID revenues with a diversified pipeline facing intense competition and…
$63.15 (as of 2026-07-16) · market cap $25.1B
Not quite? Describe exactly what you want →
Peers are drawn from IBRX's enriched profile (the same similarity signal the chat uses for "companies like IBRX"). See the full profile: IMMUNITYBIO INC (IBRX).
Last updated 2026-07-16.
Informational only — NOT financial advice. Company data is sourced from SEC EDGAR + Finnhub and shown with its as-of date.